Regeneron Pharmaceuticals | Capital Ordinaire

Prix De L'Action
764.39
Variation Quotidienne
9.36 1.24%
Mensuellement
0.15%
Annuel
14.63%
Q1 Prévisions
718.61




Capital Ordinaire Changement Date
AbbVie USD 1.77B 1.75B 2025-06
Agios Pharmaceuticals USD 58.28M 241K 2025-09
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
Amgen USD 538M 300K 2025-09
Astellas Pharma JPY 1.79B 101.21B 2025-09
AstraZeneca USD 1.55B 1.16B 2025-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 0 2025-09
GlaxoSmithKline GBP 4.03B 119.13M 2025-09
Incyte USD 196.13M 2.01M 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
J&J USD 2.41B 584K 2025-09
Kyowa Hakko Kirin JPY 523.49M 0 2025-09
Merck USD 2.5B 715.14M 2025-06
Moderna USD 391M 2M 2025-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
Novartis USD 1.94B 23.4M 2025-06
Novartis USD 1.92B 17.06M 2025-09
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
United Therapeutics USD 42.9M 42.1M 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


Regeneron Pharmaceuticals Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.